Clinical trial
Feasibility, Tolerability and Efficacy of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis Intolerant of or Contraindicated to Oral or Subcutaneous Chelation Treatment.
NCT06781099 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility, Tolerability and Efficacy of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis Intolerant of or Contraindicated to Oral or Subcutaneous Chelation Treatment.
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- January 6, 2026
- Completion date
- May 6, 2027
- Enrollment
- 13 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
myelodysplastic syndrome, myelofibrosis